Drug

Continuous erythropoietin receptor activator clinical trials

Also written Methoxy polyethylene glycol-epoetin beta, Mircera, R744 and RO0503821.

studies test it: 70
open now: 0
in phase 3: 47
first study started: 2001

How studies write it

Studies that test it under each name

Studies by the year they started

70 studies that test it; most in 2007 (21)

Studies that test continuous erythropoietin receptor activator, by start year
Year	Studies
2001	2
2002	2
2004	7
2006	2
2007	21
2008	20
2009	6
2010	4
2011	1
2012	3
2013	1
2018	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 9
Phase 3: 47
Phase 4: 14

What it is tested for

Each study’s main condition, where its own words name it.

Anemia: 41
Kidney Diseases: 14
Renal Insufficiency, Chronic: 1
Diabetic Nephropathies: 1
Multiple Myeloma: 1
Kidney Failure, Chronic: 1
Carcinoma, Non-Small-Cell Lung: 1
Malnutrition: 1
Myocardial Infarction: 1

Who runs them

Industry 67 · Other 3

Hoffmann-La Roche (60) · Chugai Pharmaceutical (6) · Hamad Medical Corporation (1) · Taipei Veterans General Hospital, Taiwan (1) · University Hospital, Basel, Switzerland (1) · Samsung Medical Center (1)

Studies

Open first, then newest update. How each study uses continuous erythropoietin receptor activator is read from its arms, and is right about nine times in ten.

Testing it · 70

See all 70 studies that test continuous erythropoietin receptor activator →

Given in every arm · 2 — continuous erythropoietin receptor activator is usual care beside what is tested

As the comparator · 6 — what is tested is compared with continuous erythropoietin receptor activator

Codes

What other systems call continuous erythropoietin receptor activator · ClinicalTrials.gg INT004878

RxNorm 729596One source FDA

System	Code	Name there	Checked by
RxNorm	729596	—	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Continuous erythropoietin receptor activator clinical trials

How studies write it

Name

Brand

Development codes

Other names